Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 2 Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 383 Carcinoma, Renal Cell 210 Urinary Bladder Neoplasms 117 Carcinoma, Non-Small-Cell Lung 99 Melanoma 78 Kidney Neoplasms 74 Carcinoma, Transitional Cell 73 Neoplasm Metastasis 72 Ovarian Neoplasms 71 Breast Neoplasms 69 Neoplasms 64 Colorectal Neoplasms 59 Squamous Cell Carcinoma of Head and Neck 50 Stomach Neoplasms 49 Uterine Cervical Neoplasms 44 Pancreatic Neoplasms 44 Triple Negative Breast Neoplasms 39 Lung Neoplasms 35 Esophageal Neoplasms 32 Non-Muscle Invasive Bladder Neoplasms 31 Endometrial Neoplasms 30 Carcinoma, Hepatocellular 29 Sarcoma 28 Small Cell Lung Carcinoma 25 Head and Neck Neoplasms 25 Colonic Neoplasms 19 Wilms Tumor 15 Metastatic Castration-resistant Prostate Cancer 14 Glioblastoma 14 Carcinoma, Merkel Cell 14

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Muscle Invasive Bladder Cancer × Genitourinary × Clear all

NCT04813107 2022-02-22

ANTICIPATE

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 1/2 Unknown

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡